You've been managing your cholesterol the best you can, but during your last check-up, you received the same message: Your "bad" LDL cholesterol was still too high. So your doctor recommended Repatha, ...
Clinical Trials Arena on MSN
Amgen’s Repatha reduces heart attack risk in real-world study
The study tracked 544,103 adults with prior statin use over a period of up to four years in routine clinical care.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Amgen (NASDAQ: AMGN) today announced new data at the American Heart Association (AHA) Scientific Sessions 2026 that further ...
Repatha works by blocking a specific enzyme in your liver to help your body remove cholesterol more effectively. It is not an immunosuppressant drug, so it doesn’t work by suppressing the immune ...
Amgen (NASDAQ: AMGN) today announced results from a large real-world study showing that treatment with Repatha ® (evolocumab) ...
Repatha is the First and Only PCSK9 Inhibitor Shown to Lower the Risk of Dying from All Causes, Including Cardiovascular Events, in High-Risk Primary Prevention Patients in a Phase 3 Trial Separate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results